Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

ARPA-H Selects Teams for Cardiovascular Agentic AI System Development

9 September 2026 · By · Wire by Fusion42

Published

9 September 2026

Topic

opportunities

◆ Sectors

Digital Health

◆ Geography

United States

◆ Source

Read at hcinnovationgroup.com →

◆ Verified

Fusion42 · 9 September 2026 · Fusion42 review

ARPA-H awarded contracts to develop an FDA-authorised agentic AI system for cardiovascular care focusing on patient support, supervisory oversight, and health system implementation to improve heart failure outcomes and reduce costs.

This Wire brief sits within Fusion42's coverage of Digital Health.

◆ ◆ The Wire takeaway

You face a new moment where AI can act as an authorised clinical team member in cardiovascular care. Moving fast on FDA clearance and integration with health records will unlock early partnerships and market access.

◆ Coverage

1 source · 9 Sep 2026

◆ Related on Wire

◆ Topics

Digital Healthagentic-aicardiovascularFDA-approvalhealthcare-aidigital-health